Non-basic melanin concentrating hormone receptor-1 antagonists

The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and opt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ROBI JEFFREY A, HERNANDEZ ANDRES S, WASHBURN WILLIAM N, MANFREDI MARK C
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ROBI JEFFREY A HERNANDEZ ANDRES S WASHBURN WILLIAM N MANFREDI MARK C
description	The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2007093509A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2007093509A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2007093509A13</originalsourceid><addsrcrecordid>eNrjZLDzy8_TTUoszkxWyE3NSczLzFNIzs9LTs0rKUosycxLV8jIL8rNz0tVKEpNTi0oyS_SNVRIzCtJTM_PyywuKeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYlAk1JL4kODjQwMzA0sjU0NLB0NjYlTBQA6QjHR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Non-basic melanin concentrating hormone receptor-1 antagonists</title><source>esp@cenet</source><creator>ROBI JEFFREY A ; HERNANDEZ ANDRES S ; WASHBURN WILLIAM N ; MANFREDI MARK C</creator><creatorcontrib>ROBI JEFFREY A ; HERNANDEZ ANDRES S ; WASHBURN WILLIAM N ; MANFREDI MARK C</creatorcontrib><description>The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=US&NR=2007093509A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=US&NR=2007093509A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROBI JEFFREY A</creatorcontrib><creatorcontrib>HERNANDEZ ANDRES S</creatorcontrib><creatorcontrib>WASHBURN WILLIAM N</creatorcontrib><creatorcontrib>MANFREDI MARK C</creatorcontrib><title>Non-basic melanin concentrating hormone receptor-1 antagonists</title><description>The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDzy8_TTUoszkxWyE3NSczLzFNIzs9LTs0rKUosycxLV8jIL8rNz0tVKEpNTi0oyS_SNVRIzCtJTM_PyywuKeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYlAk1JL4kODjQwMzA0sjU0NLB0NjYlTBQA6QjHR</recordid><startdate>20070426</startdate><enddate>20070426</enddate><creator>ROBI JEFFREY A</creator><creator>HERNANDEZ ANDRES S</creator><creator>WASHBURN WILLIAM N</creator><creator>MANFREDI MARK C</creator><scope>EVB</scope></search><sort><creationdate>20070426</creationdate><title>Non-basic melanin concentrating hormone receptor-1 antagonists</title><author>ROBI JEFFREY A ; HERNANDEZ ANDRES S ; WASHBURN WILLIAM N ; MANFREDI MARK C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2007093509A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ROBI JEFFREY A</creatorcontrib><creatorcontrib>HERNANDEZ ANDRES S</creatorcontrib><creatorcontrib>WASHBURN WILLIAM N</creatorcontrib><creatorcontrib>MANFREDI MARK C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROBI JEFFREY A</au><au>HERNANDEZ ANDRES S</au><au>WASHBURN WILLIAM N</au><au>MANFREDI MARK C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Non-basic melanin concentrating hormone receptor-1 antagonists</title><date>2007-04-26</date><risdate>2007</risdate><abstract>The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2007093509A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	Non-basic melanin concentrating hormone receptor-1 antagonists
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROBI%20JEFFREY%20A&rft.date=2007-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2007093509A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true